CNC
Centene Corp
Position levels
Currenttoday
USD 62.22
Buy <=wait / entry
USD 48.67
Trim >=take some off
USD 70.00
Thesis breakA material deterioration in medical cost trend combined with one or more adverse...
-
Scenario-weighted conviction
| Probability | Score | Contribution | |
|---|---|---|---|
| Bull case | 26% | 100 / 100 | 26.0 |
| Base case | 49% | 62 / 100 | 30.4 |
| Bear case | 25% | 10 / 100 | 2.5 |
| Weighted conviction | 59 / 100 - OPPORTUNISTIC BUY | ||
Top risks
- Q2 2026 earnings beat with adjusted EPS of $2.51 and raised 2026 GAAP and adjusted diluted EPS guidance
- Multiple analyst price target raises including Buy ratings from Truist ($80) and Barclays ($80)
- Board changes with retirement of Kenneth A. Burdick and appointment of Paul J. Diaz